Strategies for translational biomarker research and validation for personalised medicines
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: JACKSON-MATTHEWS, Dianne (ERA Consulting (Australia) Pty Ltd, Regulatory Affairs, Toowong, Australia)
- Co-author(s): Jackson-Matthews, Dianne (ERA Consulting (Australia) Pty Ltd, Toowong, Australia)
An inherent requirement for successful translational research is to enable appropriate pharmaceutical data, and nonclinical pharmacology and safety information, to be obtained to support the next step. If sufficient data are generated, with acceptable safety information, it will allow entry into the clinic, but will this be with the best possible.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.